Ursprung des Netzwerks ersten Grades von Nate Davis
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Covid Apollo Project LLC
Covid Apollo Project LLC Financial ConglomeratesFinance Covid Apollo Project LLC aims to facilitate a safe and sustainable return to work and school by identifying, assembling, developing, and scaling the most promising COVID-19 diagnostic opportunities. Covid Apollo Project is based in Boston, MA. The private company was organized and funded under the leadership of RA Capital, a biotechnology-focused investment firm, in collaboration with Redmile Group, Samsara Biocapital, Perceptive Advisors, and Bain Capital. The CEO of the company is Stefan Willemsen.
6
| Private Company | Financial Conglomerates | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nate Davis
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
Weintraub Capital Management LP
Weintraub Capital Management LP Investment ManagersFinance Founded in 1992, Weintraub Capital Management LP is a family office located in San Francisco, California. | Investment Managers | Analyst-Equity | |
Paulson & Co., Inc.
Paulson & Co., Inc. Investment ManagersFinance Paulson & Co., Inc. (PCI) is an independent hedge fund management firm headquartered in New York City. The firm was founded by John Paulson in 1994. PCI provides services to investment vehicle pools and manages accounts for banking institutions, corporations and pension and profit-sharing plans. | Investment Managers | Private Equity Investor | |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Investment Managers | Analyst-Fixed Income | |
Vensun Pharmaceuticals, Inc.
Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Pharmaceuticals: Major | Director/Board Member | |
Vitruvias Therapeutics, Inc.
Vitruvias Therapeutics, Inc. Medical/Nursing ServicesHealth Services Vitruvias Therapeutics LLC researches and develops generic drugs. The company was founded by Carl L. Whatley and Bryce Harvey and is headquartered in Auburn, AL. | Medical/Nursing Services | Director/Board Member | |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
BIOMÉRIEUX | Medical Specialties | General Counsel | |
Wake Forest University | College/University | Doctorate Degree | |
Princeton University | College/University | Undergraduate Degree | |
University of Vermont | College/University | Undergraduate Degree | |
Omniox, Inc.
Omniox, Inc. Pharmaceuticals: MajorHealth Technology Omniox, Inc. operates as a biopharmaceutical company which develops medicines for hypoxic diseases. Its technology overcomes fundamental biochemical shortcomings of hemoglobin-based and per fluorocarbon oxygen delivery approaches. The company was founded in 2006 by Stephen P. L. Cary, Michael A. Marletta, Jonathan Winger and Elizabeth Marshall Boon and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Corporate Officer/Principal | |
Kellogg School of Management | College/University | Masters Business Admin | |
UCLA Anderson School of Management | College/University | Masters Business Admin | |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
ABSCI CORPORATION | Biotechnology | Director/Board Member | |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member | |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
SeLux Diagnostics, Inc.
SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Medical Specialties | Director/Board Member | |
Soleus Capital Management LP
Soleus Capital Management LP Investment ManagersFinance Soleus Capital Management LP (Soleus Capital) is a private equity subsidiary of Soleus GP LLC founded in 2018. The firm is headquartered in Greenwich, Connecticut. | Investment Managers | Private Equity Investor | |
NanoView Biosciences, Inc.
NanoView Biosciences, Inc. Medical SpecialtiesHealth Technology NanoView Biosciences, Inc. engages in research and development of non technology. It develops ExoView platform that provides critical information that will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment. The company was founded by David Freedman and George G. Daaboul and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member | |
Redmile Group LLC /Private Equity/
Redmile Group LLC /Private Equity/ Investment ManagersFinance Redmile Group LLC /Private Equity/ (Redmile Group) is a private equity/venture capital division of Redmile Group LLC founded in 2007 by Jeremy Charles Green. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Nura Bio, Inc.
Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Tentarix Biotherapeutics LP
Tentarix Biotherapeutics LP BiotechnologyHealth Technology Tentarix Biotherapeutics LP operates as a biotechnology company. The company is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
JIYA ACQUISITION CORP. | Financial Conglomerates | Chief Investment Officer | |
Tentarix Biotherapeutics, Inc. | Director/Board Member | ||
Nalo Therapeutics, Inc.
Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nalo Therapeutics, Inc. is a company that focuses on developing therapeutics to address unmet needs in cancer. Nalo Therapeutics is based in Belmont, CA and the CEO of the company is Keith Wilson. The company targets oncogenic driver mutations and/or proteins that are often difficult to drug. The company was founded in 2017 and collaborates with UCSF scientific cofounders. | Pharmaceuticals: Major | Director/Board Member | |
ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Founder | |
NAUTILUS BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
Mako Merger Sub, Inc. | Corporate Officer/Principal | ||
ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Founder | |
OrsoBio Inc
OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Orsobio, Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapies to treat obesity and other severe metabolic disorders, such as type 2 diabetes, NASH, and severe dyslipidemias. The company is based in Palo Alto, CA. The company has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism. Orsobio has a team of physicians and scientists who are dedicated to developing therapies to treat organ failure in patients with severe metabolic disorders. The company was founded by Mani Subramanian, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Launch Therapeutics, Inc.
Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Corporate Officer/Principal | |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Investment Banks/Brokers | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 48 |
Frankreich | 2 |
Sektoral
Finance | 23 |
Health Technology | 17 |
Consumer Services | 7 |
Health Services | 2 |
Commercial Services | 2 |
Operativ
Director/Board Member | 32 |
Corporate Officer/Principal | 10 |
Private Equity Investor | 7 |
Founder | 6 |
Director of Finance/CFO | 5 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Cory Freedland | 22 |
Michael Altman | 16 |
Amrit Nagpal | 7 |
Stefan Willemsen | 6 |
Benjamin Lund | 6 |
James Cassidy | 5 |
- Börse
- Insiders
- Nate Davis
- Unternehmensverbindungen